R33.0Drug induced retention of urine

R33.0 is the ICD-10-CM diagnosis code for drug induced retention of urine. It belongs to category R33 (retention of urine), block R30-R39 (symptoms and signs involving the genitourinary system) and chapter 18 (symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified). It is billable, so it can be reported on its own for dates of service from October 1, 2026 through September 30, 2027.

Within R33 (retention of urine), R33.0 is specifically for drug induced retention of urine. Related codes cover other retention of urine (R33.8) and unspecified (R33.9).

Use an additional code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5).

It is not a CC or MCC, so as a secondary diagnosis it doesn't change the MS-DRG severity level.

In MS-DRG v44.0, it is part of the grouping logic for DRG 695 (Kidney and Urinary Tract Signs and Symptoms with MCC, relative weight 1.1139), DRG 696 (Kidney and Urinary Tract Signs and Symptoms without MCC, relative weight 0.6679), DRG 791 (Prematurity with Major Problems, relative weight 4.1075) and DRG 793 (Full Term Neonate with Major Problems, relative weight 4.2195), in MDC 11 (Diseases and Disorders of the Kidney and Urinary Tract) and MDC 15 (Newborns and Other Neonates with Conditions Originating in the Perinatal Period), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.

It has been part of ICD-10-CM since the code set took effect on October 1, 2015 and hasn't changed since.

Before ICD-10, this condition was coded in ICD-9-CM as 788.29 (other specified retention of urine).